Daily Medication Pearl: Mesalamine (Apriso)

Article

Mesalamine (Apriso) is a locally acting aminosalicylate indicated to treat and prevent flare-ups of ulcerative colitis.

Medication Pearl of the Day: Mesalamine (Apriso)

Indication: Mesalamine (Apriso) is a locally acting aminosalicylate indicated for the maintenance of diarrhea, upper abdominal pain, nausea, nasopharyngitis, flu or flu-like remission of ulcerative colitis in adults.

Insight:

  • Dosing: Four capsules once daily (1.5 g/day) in the morning with or without food. Do not co-administer with antacids.
  • Dosage forms: Extended-release capsules 0.375 g.
  • Adverse events: The most common adverse reactions (incidence ≥3%) are headache, diarrhea, upper abdominal pain, nausea, nasopharyngitis, flu or flu-like remission of ulcerative colitis in adults, illness, and sinusitis.
  • Mechanism of action: The mechanism of action of mesalamine is unknown but appears to be local to the intestinal mucosa rather than systemic.
  • Manufacturer: Catalent Pharma

Sources:

label (fda.gov)

apriso image - Google Search

Related Videos
Pride flags during pride event -- Image credit: ink drop | stock.adobe.com
Female Pharmacist Holding Tablet PC - Image credit: Tyler Olson | stock.adobe.com
African American male pharmacist using digital tablet during inventory in pharmacy - Image credit: sofiko14 | stock.adobe.com
Young woman using smart phone,Social media concept. - Image credit: Urupong | stock.adobe.com
selling mental health medication to man at pharmacy | Image Credit: Syda Productions - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Image credit: rawpixel.com | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.